Defence is the Best Attack: Immuno-Oncology Breakthroughs
Barcelona, Spain : 9 - 11 October 2017
Barcelona, Spain : 9 - 11 October 2017
Registration
(Posters may be put up from 12:00)
Welcome Lunch
Conference Welcome
Scientific Programme Committee
Session 1
Chair: Daniel Peeper
Karin de Visser Netherlands Cancer Institute (NKI), Netherlands
"Cancer-Induced Systemic Inflammation Promotes Breast Cancer Metastasis"
Zlatko Trajanoski Medical University of Innsbruck, Austria
"Dissecting tumor-immune cell interactions using immunogenomic tools"
Lynda Vuong King's College London, UK
Proffered Paper 1: "Galectin-3: a critical regulator of lung cancer growth and metastasis through modulation of macrophages and T cells"
Joan Seoane Vall d’Hebron Institute of Oncology (VHIO), Spain
"Novel therapeutic targets in brain tumors"
EXHIBITOR INTRODUCTIONS
A fun session to introduce the companies who are exhibiting at the conference.
Coffee break
Session 2
Chair: Joan Seoane
Florence Lambolez iTeos Therapeutics, Belgium
Proffered Paper 2: "A novel non-competitive and non-brain penetrant adenosine A2A receptor antagonist designed to reverse adenosine-mediated suppression of anti-tumor immunity"
Johanna Joyce Ludwig Institute for Cancer Research, Switzerland
"Microenvironmental regulation of cancer metastasis and therapeutic efficacy"
Joaquim Bellmunt IMIM-Hospital del Mar Medical Research Institute, Spain
"Strategic Immunotherapy Combinations in GU malignancies"
Keynote Lecture
Jedd Wolchok Memorial Sloan Kettering Cancer Centre (MSKCC), USA
"Immunologic Checkpoint Blockade: Exploring Combinations and Mechanisms"
Networking Reception
with drinks & hot buffet dinner
POSTER DEFENCE SESSION 1
Until 21:00
POSTER VIEWING
Until 10:00
Coffee available
POSTER SPOTLIGHT SESSION 1
2 top-scoring abstracts with be presented on a TV screen
SATELLITE SPOTLIGHT 1 - PREMIUM SPONSOR
Session 3
Chair: Johanna Joyce
Milena Kalaitsidou Manchester Cancer Research Centre, UK
Proffered Paper 3: "Best CAR expressing vehicles; peripheral versus tumour infiltrating T lymphocytes"
Alena Gros Vall d’Hebron Institute of Oncology (VHIO), Spain
"Towards personalized T cell therapies targeting the mutanome"
Keynote Lecture
Carl June Perelman School of Medicine, University of Pennsylvania, USA
"T cell therapy for cancer"
Coffee break
Pablo Umaña Roche Innovation Center Zurich, Switzerland
"Next Generation Immune Cell Agonists for Cancer Immunotherapy"
Yardena Samuels Weizmann Institute of Science, Israel
"Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma"
SATELLITE SYMPOSIUM - ELITE SPONSOR
Josep Tabernero Vall d'Hebron Institute of Oncology (VHIO), Spain
"Immunotherapy for Gastrointestinal Cancers"
Lunch
POSTER DEFENCE SESSION 2
Session 4
Chair: Ignacio Melero
Daniel Peeper Netherlands Cancer Institute (NKI), Netherlands
"Systematic genetic perturbations to reveal therapeutic melanoma vulnerabilities"
Andrea Facciabene University of Pennsylvania, USA
Proffered Paper 4: "The impact of gut microbiome on the anti-tumor effects of radiotherapy"
Javier Briones Hospital Santa Creu i Sant Pau, Spain
"Novel Immunotherapies for Hodgkin lymphoma"
Meet the Experts
Until 18:00
Alena Gros, Johanna Joyce and Carl June
An interactive session where Dr. Gros, Dr. Joyce and Dr. June will share from their personal and professional perspectives on the path to scientific leadership . There will be a chance to ask your questions.
Optional Conference Dinner
Poster Viewing
Until 10:00
Coffee available
POSTER SPOTLIGHT SESSION 2
2 top-scoring abstracts with be presented on a TV screen
SATELLITE SPOTLIGHT 2 - PREMIUM SPONSOR
Session 5
Chair: Alena Gros
Ignacio Melero Clinical University of Navarra and CIMA, Spain
"Bridging gaps in translational immuno-oncology"
Kris Thielemans Vrije Universiteit Brussel (VUB), Belgium
"TriMix technology for mRNA based vaccination"
Roderik Kortlever University of Cambridge, UK
Proffered Paper 5: "Myc cooperates with Ras by programming inflammation and immune suppression"
Coffee break
Miguel López-Botet Hospital de Mar Medical Research Institute (IMIM), Spain
"Advances in NK cell biology for cancer immunotherapy"
Leila Akkari Netherlands Cancer Institute (NKI), Netherlands
"Combinatorial targeting of tumor-associated macrophages / microglia with radiotherapy in gliomas"
Closing summary & Presentation of Award Certificates
Scientific Programme Committee
Lunch & depart